Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.

Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A.

Obstet Gynecol. 2009 Jan;113(1):26-31. doi: 10.1097/AOG.0b013e31819225cb.

PMID:
19104356
2.

Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya.

De Vuyst H, Gichangi P, Estambale B, Njuguna E, Franceschi S, Temmerman M.

Int J Cancer. 2008 Jan 1;122(1):244-6.

3.

The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.

Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB.

J Infect Dis. 2007 Sep 15;196(6):887-94. Epub 2007 Aug 7.

PMID:
17703420
4.

Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.

Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP.

Br J Cancer. 2007 May 7;96(9):1480-3. Epub 2007 Apr 17.

5.

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Gulick RM, Ribaudo HJ, Shikuma CM, Lalama C, Schackman BR, Meyer WA 3rd, Acosta EP, Schouten J, Squires KE, Pilcher CD, Murphy RL, Koletar SL, Carlson M, Reichman RC, Bastow B, Klingman KL, Kuritzkes DR; AIDS Clinical Trials Group (ACTG) A5095 Study Team.

JAMA. 2006 Aug 16;296(7):769-81.

PMID:
16905783
6.

Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.

Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH.

Gynecol Oncol. 2006 Dec;103(3):1017-22. Epub 2006 Jul 27.

7.

Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.

Luque AE, Jabeen M, Messing S, Lane CA, Demeter LM, Rose RC, Reichman RC.

J Infect Dis. 2006 Aug 15;194(4):428-34. Epub 2006 Jul 13.

PMID:
16845625
8.

Effect of HIV infection on atypical squamous cells of undetermined significance.

Duerr A, Paramsothy P, Jamieson DJ, Heilig CM, Klein RS, Cu-Uvin S, Schuman P, Anderson JR; HIV Epidemiology Research Study.

Clin Infect Dis. 2006 Mar 15;42(6):855-61. Epub 2006 Feb 10.

PMID:
16477565
9.

Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.

Bollen LJ, Chuachoowong R, Kilmarx PH, Mock PA, Culnane M, Skunodom N, Chaowanachan T, Jetswang B, Neeyapun K, Asavapiriyanont S, Roongpisuthipong A, Wright TC, Tappero JW.

Sex Transm Dis. 2006 Apr;33(4):259-64.

PMID:
16452834
10.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E.

Lancet Oncol. 2005 May;6(5):271-8.

PMID:
15863374
11.

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.

Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD.

J Infect Dis. 2005 Jan 15;191(2):182-92. Epub 2004 Dec 10.

12.

Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohort.

Kuyper LM, Wood E, Montaner JS, Yip B, O'connell JM, Hogg RS.

J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1470-6.

PMID:
15602125
13.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group.

Lancet. 2004 Nov 13-19;364(9447):1757-65.

PMID:
15541448
14.

Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.

Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, Moxley M, Palefsky J, Sacks H, Burk RD, Gange SJ.

J Natl Cancer Inst. 2004 Jul 21;96(14):1070-6.

PMID:
15265968
15.

Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.

Moscicki AB, Ellenberg JH, Farhat S, Xu J.

J Infect Dis. 2004 Jul 1;190(1):37-45. Epub 2004 Jun 8.

PMID:
15195241
16.

Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women.

Del Mistro A, Bertorelle R, Franzetti M, Cattelan A, Torrisi A, Giordani MT, Sposetti R, Bonoldi E, Sasset L, Bonaldi L, Minucci D, Chieco-Bianchi L.

Clin Infect Dis. 2004 Mar 1;38(5):737-42. Epub 2004 Feb 18.

PMID:
14986260
17.

Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.

Levi JE, Fernandes S, Tateno AF, Motta E, Lima LP, Eluf-Neto J, Pannuti CS.

Gynecol Oncol. 2004 Jan;92(1):225-31.

PMID:
14751163
18.

Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women.

Uberti-Foppa C, Ferrari D, Lodini S, Reina S, Ameglio F, Grasso MA, Gallotta G, Ferrari A, Taccagni G, Lazzarin A, Lillo FB.

AIDS. 2003 Sep 26;17(14):2136-8. No abstract available.

PMID:
14502023
19.

Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.

Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD.

J Natl Cancer Inst. 2003 Jul 16;95(14):1062-71.

PMID:
12865452
20.

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.

Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K; DIANAIDS Collaborative Study Group.

Int J STD AIDS. 2003 Jun;14(6):417-25.

PMID:
12816671

Supplemental Content

Support Center